From March 2, 2023 to August 31, 2023, the company has repurchased 1,446,646 shares. With this, the company has completed the repurchase of 1,446,646 shares under the buyback announced on March 2, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
644 GBX | -0.62% |
|
-0.62% | +0.31% |
05-30 | CORRECT (May 08): International Biotechnology half-year NAV rises | AN |
05-08 | EARNINGS: International Biotechnology bullish; Andrews Sykes profit up | AN |
![Consensus](/images/consensus_flch.gif)
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.31% | 304M | |
+9.43% | 14.8B | |
+5.20% | 6.39B | |
+27.17% | 5B | |
+8.99% | 4.32B | |
-12.87% | 3.81B | |
+15.11% | 3.51B | |
-3.29% | 3.32B | |
+11.30% | 3.14B | |
+11.62% | 2.81B |
- Stock Market
- Equities
- IBT Stock
- News International Biotechnology Trust plc
- Tranche Update on International Biotechnology Trust Plc's Equity Buyback Plan announced on March 2, 2023.